Offer - Urjas Oil for just ₹ 1 X
Digihaler SF 250 Inhaler is a prescription medicine that is available as a Inhaler. Secondary and off-label uses of Digihaler SF 250 Inhaler have also been mentioned below.
The right dosage of Digihaler SF 250 Inhaler depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Digihaler SF 250 Inhaler are Shortness of Breath, Throat Irritation, Nosebleed. While these are the most often observed Digihaler SF 250 Inhaler side effects, there are can be others also. These have been listed below. These side effects of Digihaler SF 250 Inhaler are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Digihaler SF 250 Inhaler has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Digihaler SF 250 Inhaler's effects on the liver, heart and kidney are discussed below in the Digihaler SF 250 Inhaler related warnings section.
The section on Digihaler SF 250 Inhaler contraindications lists all such conditions.
Drug interactions for Digihaler SF 250 Inhaler have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Digihaler SF 250 Inhaler is safe while driving, and is addiction.
Digihaler SF 250 Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Digihaler SF 250 Inhaler safe for pregnant women?
Digihaler SF may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Digihaler SF again without your doctor's advice.
Is the use of Digihaler SF 250 Inhaler safe during breastfeeding?
Side effects of Digihaler SF for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Digihaler SF 250 Inhaler on the Kidneys?
Digihaler SF is not harmful for kidneys.
What is the effect of Digihaler SF 250 Inhaler on the Liver?
Digihaler SF may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Digihaler SF 250 Inhaler on the Heart?
The heart can be affected by Digihaler SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Digihaler SF 250 Inhaler unless your doctor advises you to do so -
Is this Digihaler SF 250 Inhaler habit forming or addictive?
No, there is no any evidence that Digihaler SF 250 Inhaler is addictive.
Interaction between Food and Digihaler SF 250 Inhaler
Due to a lack of research, nothing can be said about the consequences of taking Digihaler SF 250 Inhaler together with food.
Interaction between Alcohol and Digihaler SF 250 Inhaler
Information about the interaction of Digihaler SF 250 Inhaler and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359